You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

myeloma post-AHCT

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in United States (Iberdomide, Daratumumab, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Durham, North Carolina
  • +5 more
Jun 22, 2022

Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
Dec 13, 2022

Multiple Myeloma Trial in Cleveland (Evomela, Next Generation Sequencing, Prochlorperazine)

Not yet recruiting
  • Multiple Myeloma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Apr 19, 2022

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

Multiple Myeloma Trial in United States (Plinabulin)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Jun 17, 2022

Multiple Myeloma Trial in United States (Iberdomide)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +7 more
Jun 10, 2022

Multiple Myeloma Trial in Montréal (Elranatamab)

Not yet recruiting
  • Multiple Myeloma
  • Montréal, Quebec, Canada
    McGill University Health Centre
Sep 21, 2023

Alvocade® (Bortezomib) Safety and Effectiveness Study

Completed
  • Multiple Myeloma, Refractory
  • (no location specified)
Aug 19, 2023

Multiple Myeloma Trial in New York (Ide-cel (bb2121))

Recruiting
  • Multiple Myeloma
  • Ide-cel (bb2121)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 6, 2022

Multiple Myeloma Trial in Houston (Isatuximab, lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2023

Multiple Myeloma Trial (Dexamethasone, Isatuximab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jan 10, 2023

Multiple Myeloma Trial in Duarte (Biospecimen Collection, Bone Marrow Aspiration, Computed Tomography)

Recruiting
  • Multiple Myeloma
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Sep 21, 2023

Based on Maintenance Therapy Post Autologous Stem Cell

Recruiting
  • Multiple Myeloma
  • Autologous Stem Cell Transplant
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jul 27, 2022

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

Multiple Myeloma Trial in Philadelphia (CART-19 cells)

Terminated
Has Results
  • Multiple Myeloma
  • CART-19 cells
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 4, 2023

Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United States (Romiplostim)

Active, not recruiting
  • Multiple Myeloma
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 7, 2022

Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

Not yet recruiting
  • Multiple Myeloma
  • +3 more
  • (no location specified)
Oct 30, 2023

Myeloma Trial in Philadelphia (Belantamab mafodotin)

Recruiting
  • Myeloma
  • Belantamab mafodotin
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Jun 13, 2022

Multiple Myeloma Trial (Isatuximab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 19, 2022

Bone Metastases, Lymphoma, Multiple Myeloma Trial in Saint Louis (Ketorolac, Normal saline, Acetaminophen)

Recruiting
  • Bone Metastases
  • +4 more
  • Saint Louis, Missouri
    Saint Louis University
Dec 6, 2022

Multiple Myeloma Trial in Birmingham (DaraVRD)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
    University of Alabama at Birmingham
Oct 20, 2021

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Duarte, California
  • +9 more
Jan 11, 2023

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,

Active, not recruiting
Has Results
  • Stage I Multiple Myeloma
  • +2 more
  • Chicago, Illinois
  • +4 more
Sep 3, 2022

Multiple Myeloma Trial in Hackensack (Pembrolizumab, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
    John Theurer Cancer Center-Hackensack Meridian Health
Jan 18, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Ixazomib Citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022